Clarity Pharmaceuticals Ltd. Financial Overview
Clarity Pharmaceuticals Ltd.'s market cap is currently AU$1.13B. The company's EPS TTM is AU$-0.12; its P/E ratio is -15.12; Clarity Pharmaceuticals Ltd. is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$-0.12. See an overview of income statement, balance sheet, and cash flow financials.